"Capital Cardiology Associates is a benchmark cardiology practice committed to improving our patients' quality of life. By providing state of the art diagnostics, board certified physicians and a caring and competent staff, we offer the highest quality of care in a comfortable, supportive atmosphere."

During the past decade, Capital Cardiology Associates conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Cardiology Associates" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Cardiology Associates" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Capital Cardiology Associates" are "Heart Failure" (5 trials), "Cardiovascular Disease" (3 trials), "Coronary Artery Disease" (3 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "Capital Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Capital Cardiology Associates" are "Drug" (7 trials), "Device" (6 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Acetylsalicylic acid" (2 trials), "Apixaban" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials) and "Acetylsalicylic acid placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Cardiology Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Capital Cardiology Associates". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Capital Cardiology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Capital Cardiology Associates has several departments that took part in Clinical trials: "Capital Cardiology Associates" - 4 trials